Inventor · disambiguated record
Gerhard Koenig
Also filed as: KOENIG GERHARD · KOENIG GERHARD F
21 granted patents·23 pending applications·131 citations·filing 1982–2020
94Inventor score
Files withENVIVO PHARMACEUTICALS INC14CORNING GLASS WORKS6FORUM PHARMACEUTICALS INC4KOENIG GERHARD4DAIMLER CHRYSLER AG3
Top patents by PatentIndex Score
44 records- 0190USD280242SGlobe or the likeCORNING GLASS WORKS·Filed 1983·Granted Aug 20, 1985·40 cites·1 claims
- 0287US7513239B2Compression ignition internal combustion engineDAIMLER AG·Filed 2004·Granted Apr 7, 2009·27 cites·16 claims
- 0384US8815933B2Treatment of cognitive disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereofENVIVO PHARMACEUTICALS INC·Filed 2014·Granted Aug 26, 2014·4 cites·13 claims
- 0478US8569354B2Treatment of cognitive disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereofENVIVO PHARMACEUTICALS INC·Filed 2012·Granted Oct 29, 2013·2 cites·26 claims
- 0576US8642638B2Treatment of cognitive disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereofCHESWORTH RICHARD·Filed 2009·Granted Feb 4, 2014·1 cites·25 claims
- 0674US9540380B2Imidazotriazinone compoundsIRONWOOD PHARMACEUTICALS INC·Filed 2014·Granted Jan 10, 2017·1 cites·1 claims
- 0773US2015265583A1Treatment of Cognitive Disorders with (R)-7-Chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-Carboxamide and Pharmaceutically Acceptable Salts ThereofFORUM PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0872US11682875B2Pressing jaws for crimping pliersRENNSTEIG WERKZEUGE GMBH·Filed 2018·Granted Jun 20, 2023·2 cites·6 claims
- 0970US7225791B2Compression-ignition internal combustion engineDAIMLER CHRYSLER AG·Filed 2004·Granted Jun 5, 2007·11 cites·12 claims
- 1070US2014148479A1Treatment of Cognitive Disorders with (R)-7-Chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-Carboxamide and Pharmaceutically Acceptable Salts ThereofENVIVO PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1169US2018271844A1Treatment of Cognitive Disorders with (R)-7-Chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-Carboxamide and Pharmaceutically Acceptable Salts ThereofFORUM PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1265USD280239SShade for light fixturesCORNING GLASS WORKS·Filed 1983·Granted Aug 20, 1985·9 cites·1 claims
- 1360US11462874B2Crimping pliersRENNSTEIG WERKZEUGE GMBH·Filed 2018·Granted Oct 4, 2022·1 cites·9 claims
- 1458US9585877B2Methods of maintaining, treating or improving cognitive functionFORUM PHARMACEUTICALS INC·Filed 2013·Granted Mar 7, 2017·0 cites·40 claims
- 1555USD280240SShade for light fixturesCORNING GLASS WORKS·Filed 1983·Granted Aug 20, 1985·6 cites·1 claims
- 1653US7059295B2Self-igniting internal combustion engineDAIMLER CHRYSLER AG·Filed 2003·Granted Jun 13, 2006·12 cites·42 claims
- 1752US2017152265A1Imidazotriazinone compoundsIRONWOOD PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1851US2018214431A1Methods of Maintaining, Treating or Improving Cognitive FunctionAXOVANT SCIENCES GMBH·Filed 2017·Application pending·0 cites
- 1950US2005132425A1Transgenic flies expressing Abeta42-ItalianENVIVO PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2049US7013861B1Self-igniting internal combustion engineDAIMLER CHRYSLER AG·Filed 2003·Granted Mar 21, 2006·11 cites·34 claims
- 2149US2005108779A1Transgenic flies expressing Abeta42-ItalianENVIVO PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2247US2005132421A1Transgenic flies expressing Abeta42-ArcticENVIVO PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2347US2005132422A1Transgenic flies expressing Abeta42-IowaENVIVO PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2447US2005132423A1Transgenic flies expressing Abeta42-FlemishENVIVO PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2547US2015126546A1Treatment of Cognitive Disorders with Certain Alpha-7 Nicotinic Acid Receptors in Combination with Acetylcholinesterase InhibitorsFORUM PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2647US2005132424A1Transgenic flies expressing Abeta42-DutchENVIVO PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2747US2014163067A1Methods of Treatment of Limited Cognitive ImpairmentKOENIG GERHARD·Filed 2012·Application pending·0 cites
- 2846US2004255342A1Transgenic flies expressing Abeta42-IowaENVIVO PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2946US2004250302A1Transgenic flies expressing Abeta42-dutchENVIVO PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 3046US2004244064A1Transgenic flies expressing Abeta42-FlemishENVIVO PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 3146US2013231365A1Treatment of Inflammation with Certain Alpha-7 Nicotinic Acid Receptor Agonists in Combination with Acetylcholinesterase InhibitorsKOENIG GERHARD·Filed 2011·Application pending·0 cites
- 3246US2004255341A1Transgenic flies expressing Abeta42-ArcticENVIVO PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 3345US12300980B2Insulating-stripping tool designed as a hand tool, cutting part for an insulation-stripping tool and method for stripping a cableRENNSTEIG WERKZEUGE GMBH·Filed 2020·Granted May 13, 2025·0 cites·14 claims
- 3443USD278748SShade or the likeCORNING GLASS WORKS·Filed 1982·Granted May 7, 1985·3 cites·1 claims
- 3543US2021163471A1Progranulin modulators and methods of using the sameARKUDA THERAPEUTICS·Filed 2018·Application pending·0 cites
- 3641US11352982B2Feed and ignition device for a gas engine and method for operating a feed and ignition device for a gas engineDAIMLER AG·Filed 2018·Granted Jun 7, 2022·0 cites·16 claims
- 3740US2014155429A1Treatment of Cognitive Disorders with Certain Alpha-7 Nicotinic Acid Receptor Agonists in Combination with NicotineENVIVO PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 3839US2014179678A1Methods of targeted treatment of frontotemporal lobar degenerationPATZKE HOLGER·Filed 2012·Application pending·0 cites
- 3937US2011124631A1Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptors in combination with acetylcholinesterase inhibitorsKOENIG GERHARD·Filed 2010·Application pending·0 cites
- 4035US10183938B2Geminal substituted quinuclidine amide compounds as agonists of α-7 nicotonic acetylcholine receptorsAXOVANT SCIENCES GMBH·Filed 2015·Granted Jan 22, 2019·0 cites·15 claims
- 4135USD278938SLamp chimneyCORNING GLASS WORKS·Filed 1982·Granted May 21, 1985·1 cites·1 claims
- 4231US2013225560A1Treatment of Cognitive Disorders with Certain Alpha-7 Nicotinic Acid Receptor Agonists in Combination with Acetylcholinesterase InhibitorsKOENIG GERHARD·Filed 2011·Application pending·0 cites
- 4330US8393194B2Crimping toolNOTHNAGEL HORST·Filed 2009·Granted Mar 12, 2013·0 cites·15 claims
- 4427USD280241SChimney for light fixtures or the likeCORNING GLASS WORKS·Filed 1983·Granted Aug 20, 1985·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Gerhard Koenig files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →